Granules India rises on securing US regulatory clearance

Granules India

29/10/2025 08:00

** Granules India GRAN.NS rises 2% to 580 rupees; eyes fourth straight session of gains

** Paracetamol maker receives Establishment Inspection Report from U.S. Food and Drug Administration for its Hyderabad facility

** Regulator completes inspection, classifies facility as  Voluntary Action Indicated, implying no recommendations from regulator

** Co says facility is its largest Paracetamol manufacturing plant by volume

** YTD, GRAN down 2%

 (Reporting by Komal Salecha)

 ((Komal@thomsonreuters.com;))